Bio-Path Holdings Schedules Special Stockholder Meeting for January 22, 2024

TL;DR

**Bio-Path Holdings, Inc. will hold a special meeting of stockholders on January 22, 2024, to discuss company business.**

AI Summary

BIO-PATH HOLDINGS INC (BPTH) filed a Proxy Statement (DEF 14A) with the SEC on January 4, 2024. A special meeting of stockholders for Bio-Path Holdings, Inc. is scheduled for January 22, 2024, at 4:00 p.m. Central Standard Time. The meeting will be held at Winstead PC, 24 Waterway Avenue, Suite 500, The Woodlands, Texas 77380. Stockholders are encouraged to read the proxy materials, including the Proxy Statement and Form of Proxy. The company urges stockholders to vote regardless of attendance to ensure a quorum. The meeting's purpose is to address business matters presented to the stockholders.

Why It Matters

For investors and stakeholders tracking BIO-PATH HOLDINGS INC, this filing contains several important signals. The meeting is crucial for stockholders to participate in important company decisions and ensure a quorum for valid business transactions. The proxy statement provides essential information for informed voting, highlighting the company's commitment to transparency and stockholder engagement.

Risk Assessment

Risk Level: — BIO-PATH HOLDINGS INC shows moderate risk based on this filing. The filing is a routine proxy statement for a special meeting, with no immediate financial or operational disclosures that would indicate high risk.

Analyst Insight

Stockholders should review the proxy materials carefully and vote their shares to ensure their voice is heard on company matters.

Key Numbers

• January 22, 2024 — Special Meeting Date (Date of the special meeting of stockholders)
• 4:00 p.m. CST — Special Meeting Time (Time of the special meeting of stockholders)
• 0001104659-24-001348 — Accession Number (SEC filing accession number)
• 20240104 — Filing Date (Date the filing was made)

Key Players & Entities

• BIO-PATH HOLDINGS INC (company) — Registrant
• Peter H. Nielsen (person) — Chairman and Chief Executive Officer
• January 22, 2024 (date) — Date of Special Meeting
• Winstead PC (company) — Location of Special Meeting
• 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (address) — Company Address
• 24 Waterway Avenue, Suite 500, The Woodlands, Texas 77380 (address) — Meeting Location Address

FAQ

Risk Factors

• Special Meeting Logistics [low — operational]: The company is holding a special meeting of stockholders on January 22, 2024, at a specific location and time, requiring stockholder participation.

Industry Context

Bio-Path Holdings, Inc. operates in the pharmaceutical preparations industry.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101 concerning proxy statements.

What Investors Should Do

1. Review the proxy statement for details on the business to be conducted.
2. Vote your shares by the deadline, either online or by mail, to ensure representation.
3. Attend the special meeting on January 22, 2024, if possible.

Key Dates

• 2024-01-22: Special Meeting of Stockholders — Key date for stockholder participation in company decisions.
• 2024-01-04: Filing Date — Date the definitive proxy statement was filed with the SEC.

Year-Over-Year Comparison

This is a definitive proxy statement (DEF 14A) filed on January 4, 2024, announcing a special meeting of stockholders scheduled for January 22, 2024. It does not contain comparative financial data from a previous filing.

Key Financial Figures

• $0.001 — f the Company's common stock, par value $0.001 per share, at a ratio of up to 1-for-50
• $8,500 — cial Meeting for a fee of approximately $8,500 plus out-of-pocket expenses. The Comp
• $1.00 — price that is greater than or equal to $1.00 per share in order to continue to be li

Filing Documents

• tm2332992-2_def14a.htm (DEF 14A) — 223KB
• px_23biopathproxy1pg01-bw.jpg (GRAPHIC) — 323KB
• px_23biopathproxy1pg02-bw.jpg (GRAPHIC) — 168KB
• 0001104659-24-001348.txt ( ) — 844KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 5 PROPOSAL 1: APPROVAL OF AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF THE COMPANY'S COMMON STOCK AT A RATIO OF UP TO 1-FOR-50, TO BE DETERMINED BY THE BOARD 6 Reasons for the Reverse Stock Split 6 Certain Risks Associated with the Reverse Stock Split 7 Determination of Reverse Stock Split Ratio 8 Impact of the Reverse Stock Split, if Implemented 8 Procedure for Effecting the Reverse Stock Split 8 Effect of Reverse Stock Split Resulting in Fractions of a Share 9 Effect on Certificated Shares 9 Effect on Registered "Book-Entry" Holders of Common Stock 9 Effect on Beneficial Holders of Common Stock 9 Effect of Reverse Split on Number of Shares Outstanding 10 Effect of Reverse Split on Number of Authorized Shares Available for Issuance 10 Anti-takeover Implications of Reverse Stock Split 11 No Going Private Transaction 11 No Appraisal Rights 11 Accounting Matters 11 Certain United States Federal Income Tax Consequences 11 Required Vote 12 PROPOSAL 2: THE ADJOURNMENT PROPOSAL 13 General 13 Required Vote 13 OTHER MATTERS 14 APPENDIX A A-1 i TABLE OF CONTENTS BIO-PATH HOLDINGS, INC. 4710 Bellaire Boulevard, Suite 210 Bellaire, Texas 77401 PROXY STATEMENT SPECIAL MEETING OF STOCKHOLDERS January 22, 2024 Bio-Path Holdings, Inc. (the "Company") is furnishing this Proxy Statement and the enclosed proxy card in connection with the solicitation of proxies by the Board of Directors (the "Board") of the Company for use at a Special Meeting of Stockholders to be held on January 22, 2024 at 4:00 p.m., Central Standard Time, at Winstead PC, 24 Waterway Avenue, Suite 500, The Woodlands, Texas 77380, and at any adjournments thereof (the "Special Meeting"). These materials are being mailed to stockholders of the Company on or about January 4, 2024. The Special Meetin

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth information regarding shares of our common stock beneficially owned at December 21, 2023 by: (i) each of our named executive officers ("NEOs") and directors; (ii) all executive officers and directors as a group; and (iii) each person known by us to beneficially own 5% or more of the outstanding shares of our common stock. The information in this table is based solely on statements in filings with the SEC or other reliable information. Unless otherwise indicated in the footnotes to the table, each stockholder named in the table has sole voting and investment power with respect to the shares of common stock set forth opposite the stockholder's name. Name of Beneficial Owner Amount and Nature of Beneficial Percent of Class Peter H. Nielsen (1) (2) 254,773 2.02 % Douglas P. Morris (1) (3) 37,129 * Heath W. Cleaver (1) (4) 39,875 * Paul D. Aubert (1) (5) 39,500 * Aline B. Sherwood (1) (6) 17,500 * All executive officers and directors as a group (7) 388,777 3.05 % * Less than 1% (1) These are our NEOs and directors. (2) Includes 25,823 shares owned of record and 228,950 shares issuable upon the exercise of options that are that are exercisable within 60 days. (3) Includes 8,050 shares held by Hyacinth Resources, LLC and 121 shares held by Sycamore Ventures, LLC. Mr. Morris disclaims beneficial ownership of the shares held by Sycamore Ventures, LLC except to the extent of his pecuniary interest therein. Also includes 28,958 shares issuable upon the exercise of options that are exercisable within 60 days. (4) All 39,875 shares are issuable upon the exercise of options that are exercisable within 60 days. (5) All 39.500 shares are issuable upon the exercise of options that are exercisable within 60 days. (6) All 17,500 shares are issuable upon the exercise of options that are exercisable with

View Full Filing

View this DEF 14A filing on SEC EDGAR